全国服务咨询热线:
15921799099
15921799099
荷兰ipatherapeutics生物公司是ImmunoPrecise Antibodies Ltd.（NASDAQ: IPA）旗下的重要品牌，是一家在生物治疗领域具有影响力的合同研究组织。公司成立于1989年，总部位于美国法戈，并在北美和欧洲设有多个分支机构，员工规模在51至200人之间。该公司专注于抗体发现与开发服务，致力于通过融合生物技术和人工智能技术推动生物治疗创新。
ipatherapeutics的核心技术平台包括其独特的B细胞选择®兔单克隆抗体技术、转基因动物模型以及多通道膜蛋白靶向抗体平台。兔免疫系统的优势在于能产生高特异性和高亲和力抗体，结合公司功能优先的B细胞选择工作流程，可在早期识别出优秀的诊断抗体面板。其转基因动物模型能够针对小于3 kDa的小分子和具有复杂二级结构的蛋白质生成大量序列多样、生物学相关的候选抗体。在多通道膜蛋白靶向抗体方面，公司通过BLI平台进行特异性测试，结合抗体面板的亲和力排名或表位映射和分箱，实现分子质量优化。
公司近年来积极整合人工智能技术，特别是其LENSai™计算软件平台和HYFT技术，通过多组学建模和复杂的人工智能系统支持抗体发现过程。2023年，公司通过收购BioStrand获得了一套基于云的革命性解决方案，能够加速多组学研究数据分析。此外，公司的OmniChicken®发现平台是行业内成功改造的鸟类平台，具有能够产生人类序列抗体库的免疫系统。
ipatherapeutics提供抗体开发服务，涵盖从定制单克隆和多克隆抗体开发、抗体工程与优化到抗体生产和纯化的完整流程。公司服务对象包括制药公司、生物技术企业、研究机构和学术界客户。其产品线涵盖多种研究用抗体，包括针对各种疾病靶点的单克隆抗体，例如货号MQ13.101的鼠标抗瓜氨酸纤维蛋白原抗体和货号MQR2.201的人抗凋亡 cleavage product of human U1-70K抗体等。
公司将自身定位为“生物治疗智能的中心"，通过结合专业知识和技术，为制药合作伙伴提供高度专业化的全连续治疗性抗体发现、开发和对外许可服务。公司的使命是为制药客户提供智能和技术来治疗疾病，目标是提高生物治疗的特异性。
关键词：ipatherapeutics，ipatherapeutics上海代理，ipatherapeutics中国代理，ipatherapeutics北京代理，ipatherapeutics江苏代理， ipatherapeutics广东代理,N002-100ML, N001-0.5mg, N001-0.1mg, R001-100ML, L101-0.025mg immunoprecise u-proteinexpress、ipatherapeutics、免疫精确抗体、IPA生物治疗、B细胞选择兔单克隆抗体、人工智能抗体发现、LENSai平台、OmniChicken技术、转基因动物模型、多通道膜蛋白靶向、抗体发现服务、生物治疗智能、定制抗体开发、HYFT技术、治疗性抗体、生物制药研发、GPCR抗体、结构生物学、抗体人源化、生物标记物发现、临床前开发。
特别告知：为保证产品质量与良好性能，所以在购买相应产品的同时我司会收取一定量的运输费用！！！本次报价有效时间为2025年12月19日---2026年12月20日。
（*此为部分产品价格,完整价格请下载文件)
货号 | 品名 | 规格 | 价格 | 品牌 |
N001-0.1 mg | WNT Surrogate-Fc Fusion Protein | 100µg | 17641.8 | ipatherapeutics |
N001-0.5 mg | WNT Surrogate-Fc Fusion Protein | 500µg | 70270.2 | ipatherapeutics |
N001-1.0 mg | WNT Surrogate-Fc Fusion Protein | 1mg | 105454.8 | ipatherapeutics |
N002-100 ml | Noggin-Fc Fusion Protein Conditioned Medium | 100ml | 24690.6 | ipatherapeutics |
N002-200 ml | Noggin-Fc Fusion Protein Conditioned Medium | 200ml | 44569.8 | ipatherapeutics |
N002-500 ml | Noggin-Fc Fusion Protein Conditioned Medium | 500ml | 64548 | ipatherapeutics |
O001 | OIT1, Murine | 100ug | 9603 | ipatherapeutics |
P001 | Platelet Derived Growth Factor Βeta, Human | 100ug | 9999 | ipatherapeutics |
P002 | PDGF-R Beta-(His)C, ECD, Human, Recombinant | 100ug | 10711.8 | ipatherapeutics |
R001-100 ml | Rspo3-Fc Fusion Protein Conditioned Medium | 100ml | 24690.6 | ipatherapeutics |
R001-200 ml | Rspo3-Fc Fusion Protein Conditioned Medium | 200ml | 44569.8 | ipatherapeutics |
R001-500 ml | Rspo3-Fc Fusion Protein Conditioned Medium | 500ml | 64548 | ipatherapeutics |
R002-0.1 mg | mRSPO1-Fc | 0.1mg | 9801 | ipatherapeutics |
R002-0.5 mg | mRSPO1-Fc | 0.5mg | 38966.4 | ipatherapeutics |
R002-1.0 mg | mRSPO1-Fc | 1.0mg | 58429.8 | ipatherapeutics |
R005-0.1 mg | mRSPO1-his | 0.1mg | 9801 | ipatherapeutics |
R005-0.5 mg | mRSPO1-his | 0.5mg | 38966.4 | ipatherapeutics |
R005-1.0 mg | mRSPO1-his | 1.0mg | 58429.8 | ipatherapeutics |
R006-0.1 mg | hRSPO1-Fc | 0.1mg | 9801 | ipatherapeutics |
R006-0.5 mg | hRSPO1-Fc | 0.5mg | 38966.4 | ipatherapeutics |
R006-1.0 mg | hRSPO1-Fc | 1.0mg | 58429.8 | ipatherapeutics |
R006-2.0 mg | hRSPO1-Fc | 2.0mg | 88723.8 | ipatherapeutics |
R007-0.1 mg | hRSPO1-his | 0.1mg | 9801 | ipatherapeutics |
R007-0.5 mg | hRSPO1-his | 0.5mg | 38966.4 | ipatherapeutics |
R007-1.0 mg | hRSPO1-his | 1.0mg | 58429.8 | ipatherapeutics |
R009-10 ml | enhanced Rspo3-Fc Fusion Protein Conditioned Medium | 10ml | 24472.8 | ipatherapeutics |
R009-50 ml | enhanced Rspo3-Fc Fusion Protein Conditioned Medium | 50ml | 97891.2 | ipatherapeutics |
R010-0.1 mg | enhanced Rspo3-Fc Fusion Protein | 0.1mg | 24472.8 | ipatherapeutics |
R010-0.5 mg | enhanced Rspo3-Fc Fusion Protein | 0.5mg | 97891.2 | ipatherapeutics |
S001 | Sp-D, Porcine | 100ug | 9603 | ipatherapeutics |
S002 | Sp-D, Human | 100ug | 9603 | ipatherapeutics |
S003A | Syndecan-1-(His)C, Human, Recombinant, higher glycosylation than S003B | 100µg | 10098 | ipatherapeutics |
S003B | Syndecan-1-(His)C, Human, Recombinant, lower glycosylation than S003A | 100µg | 10098 | ipatherapeutics |
T004 | Tev Protease | 1mg | 18255.6 | ipatherapeutics |
T005 | TFPI-Alpha-(His)C, Human, Recombinant | 100µg | 11226.6 | ipatherapeutics |
T006 | Thrombomodulin-(Tev-His)N, Human, Recombinant | 100µg | 11226.6 | ipatherapeutics |
U001 | Upar-(His)N, Human, Recombinant | 100ug | 10098 | ipatherapeutics |
V001 | vWF-A1 Domain, Human, Residues 1261-1468 | 100ug | 8375.4 | ipatherapeutics |
V002 | vWF-A1 Domain, Human, Residues 1261-1468, VWD Type 2B, Recombinant | 100ug | 8989.2 | ipatherapeutics |
V003 | vWF-A1 Domain, Human, Residues 1238-1481, Glycosylated | 100ug | 10711.8 | ipatherapeutics |
V004 | vWF-A3 Domain, Human, Residues 1683-1874, Recombinant | 100ug | 9603 | ipatherapeutics |
V005 | vWF-A3 Domain, Human, Residues 1683-1874, without Tag, Recombinant | 100ug | 10197 | ipatherapeutics |
V010 | VCAM1-(His)N, Transcript A, Human, Recombinant | 100ug | 11226.6 | ipatherapeutics |
V011 | vWF-A1-A2-A3-(his)C domain, Human, Residues 1261-1874, Recombinant | 100µg | 13068 | ipatherapeutics |
V012 | vWF-A1-A2-A3-R1597Q-(his)C domain, Human, Residues 1261-1874, Recombinant | 100µg | 13068 | ipatherapeutics |
PODI-0005 | mouse anti-barley LTP | 100ug | 8375.4 | ipatherapeutics |
PODI-0006 | mouse anti-human ACTH (POMC) | 100ug | 8375.4 | ipatherapeutics |
PODI-0007 | mouse anti-rabbit uteroglobuline | 100ug | 8375.4 | ipatherapeutics |
PODI-0008 | mouse anti-Trichinella spiralis | 100ug | 8375.4 | ipatherapeutics |
PODI-0009 | mouse anti-Leptospira interogans OMP (2D1D7) | 100ug | 8375.4 | ipatherapeutics |
PODI-0011 | mouse anti-Cowdria ruminantium OMP (1E5H8) | 100ug | 8375.4 | ipatherapeutics |
PODI-0012 | mouse anti-Cowdria ruminantium OMP (4F10B4) | 100ug | 8375.4 | ipatherapeutics |
PODI-0013 | mouse anti-human HSP60, specific for eukaryotic HSP60 | 100ug | 8375.4 | ipatherapeutics |
PODI-0014 | mouse anti-human HSP60, specific for eukaryotic and prokaryotic HSP60 | 100ug | 8375.4 | ipatherapeutics |
PODI-0015 | mouse anti-HSP70, cross reactive with E.coli DNAK | 100ug | 8375.4 | ipatherapeutics |
PODI-0016 | mouse anti-sheep IgE | 100ug | 8375.4 | ipatherapeutics |
PODI-0017 | mouse anti-rat gonocytes | 100ug | 8375.4 | ipatherapeutics |
PODI-0018 | mouse anti-chloroamphenicol | 100ug | 8375.4 | ipatherapeutics |
PODI-0019 | mouse anti-human PLK1 | 100ug | 8375.4 | ipatherapeutics |
PODI-0023 | mouse anti-human PBDK1 | 100ug | 8375.4 | ipatherapeutics |
PODI-0027 | mouse anti-human PBDK2 | 100ug | 8375.4 | ipatherapeutics |
PODI-0031 | mouse anti-human Mps1 | 100ug | 8375.4 | ipatherapeutics |
PODI-0034 | mouse anti-GFP | 100ug | 8375.4 | ipatherapeutics |
PODI-0035 | mouse anti-human MASP-2 | 100ug | 8375.4 | ipatherapeutics |
PODI-0037 | mouse anti-human FAM3D | 100ug | 8375.4 | ipatherapeutics |
PODI-0038 | mouse anti-human FAM3D, cross reacts with mouse Oit-1 | 100ug | 8375.4 | ipatherapeutics |
PODI-0039 | mouse anti-human MBL-2 | 100ug | 8375.4 | ipatherapeutics |
PODI-0040 | human Placental Alkaline Phosphatase (2B4H11) | 100ug | 8375.4 | ipatherapeutics |
PODI-0042 | human Placental Alkaline Phosphatase (23F4G3) | 100ug | 8375.4 | ipatherapeutics |
PODI-0043 | human Intestinal Alkaline Phosphatase (8A8E3) | 100ug | 8375.4 | ipatherapeutics |
PODI-0058 | mouse anti-rat CD40 | 100ug | 8375.4 | ipatherapeutics |
PODI-0059 | mouse anti-Ovalbumin | 100ug | 8375.4 | ipatherapeutics |
PODI-0061 | mouse anti-Neisseria meningitidis Omp85 (32F9) | 100ug | 8375.4 | ipatherapeutics |
PODI-0063 | mouse anti-Lactobacillus rhamnosus SpaC | 100ug | 8375.4 | ipatherapeutics |
PODI-0064 | mouse anti-Streptococcus pneumonia PspA | 100ug | 8375.4 | ipatherapeutics |
PODI-0065 | mouse anti-human PDGF | 100ug | 8375.4 | ipatherapeutics |
PODI-0068 | mouse anti-human CD36, cross reacts with dog | 100ug | 8375.4 | ipatherapeutics |
PODI-0069 | mouse anti-STREP-II tag | 100ug | 8375.4 | ipatherapeutics |
PODI-0070 | mouse anti-human Mart-1, IHC on melanoma tissue | 100ug | 8375.4 | ipatherapeutics |
PODI-0071 | mouse anti-human BCHE | 100ug | 8375.4 | ipatherapeutics |
PODI-0073 | mouse anti-human IGFBP-7 | 100ug | 8375.4 | ipatherapeutics |
PODI-0076 | mouse anti-Neisseria meningitidis Omp85 | 100ug | 8375.4 | ipatherapeutics |
PODI-0077 | mouse anti-N-terminal-His tag | 100ug | 8375.4 | ipatherapeutics |
PODI-0079 | human Intestinal Alkaline Phosphatase, detector antibody in ELISA with 8A8E3 | 100ug | 8375.4 | ipatherapeutics |
PODI-0080 | mouse anti-human Factor V | 100ug | 8375.4 | ipatherapeutics |
PODI-0081 | mouse anti-human PKM2 | 100ug | 8375.4 | ipatherapeutics |
PODI-0082 | mouse anti-human CD63 | 100ug | 8375.4 | ipatherapeutics |
PODI-0083 | mouse anti-human CD31 | 100ug | 8375.4 | ipatherapeutics |
PODI-0084 | mouse anti-human CD41 | 100ug | 8375.4 | ipatherapeutics |
PODI-0085 | mouse anti-human CD61 | 100ug | 8375.4 | ipatherapeutics |
PODI-0086 | mouse anti-human CD42B | 100ug | 8375.4 | ipatherapeutics |
PODI-0087 | mouse anti-human vWF | 100ug | 8375.4 | ipatherapeutics |
PODI-0088 | mouse anti-Thrombospondin | 100ug | 8375.4 | ipatherapeutics |
PODI-0089 | mouse anti-Annexin-5 | 100ug | 8375.4 | ipatherapeutics |
PODI-0090 | mouse anti-human Protein S | 100ug | 8375.4 | ipatherapeutics |
PODI-0091 | mouse anti-CD40 (8B9) | 100ug | 8375.4 | ipatherapeutics |
PODI-0092 | mouse anti-CD40 (16B4E4) | 100ug | 8375.4 | ipatherapeutics |
PODI-0093 | mouse anti-NY-ESO | 100ug | 8375.4 | ipatherapeutics |
电话
微信
当前位置：
地址：上海浦东川沙镇川沙路6619号上海起发实验试剂有限公司
邮箱：xs1@78bio.com
传真：021-50724961